/Investor DB

Tekedia Capital — 2024 Investments

2 investments dated 2024 · listed companies and verified rows first · show all

Exin Therapeuticsexintherapeutics.comin𝕏Seed · Nov 2024

Exin Therapeutics develops an AI-guided drug discovery platform that uses experimental mouse studies to identify neurological therapies, starting with epilepsies linked to autism and Parkinson's disease.

BiotechHealthtechSan Francisco, US

Gabriel Ocana Santero(CEO)inMarko Tvrdic(COO)inIvan Alex Priela Lazarte(Executive Officer, Director)inIvan Lazarte(Founder)

Co-investorsAlumni VenturesMULTIMODAL VENTURESY Combinator468 CapitalFounder CapitalOurCrowd+1 more

Winich Farmswinichfarms.cominOct 2024 · $3M

WinichFarms operates a technology-driven agribusiness platform that connects farmers directly with business buyers, handling pricing and supply chain logistics for food distribution.

AgTechB2B MarketplacesFintechFoodTech

Riches Attai(Co-Founder & CEO)inWinner Attai(Co-Founder & COO)Chichebem Jibunoh(Co-Founder & CTO)

Co-investorsAcasia VenturesCairo Angels Syndicate FundExpert DOJOFounders Factory AfricaPlug and Play VenturesSahel Capital+2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.